Latest enhancements
Updated: 21st March 2024
Planned enhancements
Updated: 21st March 2024
Content set | Sources | Frequency |
Sales | IQVIA | quarterly, as received |
API consumption | IQVIA | quarterly, as received |
Therapeutic Area | EPhMRA | annual, as published |
Technologies | Proprietary | weekly |
Chemical Structure | Proprietary | weekly |
API Availability | Proprietary algorithm | weekly |
US Generic Forecast | Proprietary algorithm | weekly |
Content set | Sources | Frequency |
GDUFA Fee payment | US FDA | bi-annual, as published by source |
Facility Registration Date | US FDA | bi-annual, as published by source |
FDA Warning Letter | US FDA | weekly, as published by source |
FDA Inspection date | US FDA | bi-annual, as published by source |
Manufacturing Status | Proprietary algorithm | weekly |
Corporate API Rating | Proprietary algorithm | weekly |
Available for Reference US DMF | US FDA | weekly, as published by source |
Issued GMP certificates | Brazil ANVISA | variable, as published/received |
China FDA | variable, as published/received | |
EudraGMDP | variable, as published/received | |
India CDSCO | variable, as published/received | |
Japan PMDA | variable, as published/received | |
Mexico COFEPRIS | variable, as published/received | |
Taiwan KFDA | variable, as published/received | |
WHO | variable, as published/received | |
Facility Inspections | Regulatory agencies | variable, as published/received |
Import and Manufacturing registrations | EudraGMDP | variable, as published/received |
US FDA | variable, as published/received | |
China CFDA | variable, as published/received |
Content set | Sources | Frequency |
US DMF | US FDA | quarterly, as published by source |
COS/CEP | EU EDQM | weekly, as published by source |
JP DMF | Japanese PMDA | weekly, as published by source |
KR DMF | Korea KFDA | quarterly, as published by source |
CN DMF | China NMPA | monthly, as published/received by source |
Content set | Sources | Frequency |
WW Approvals | Brazil ANVISA | variable, as published/received |
EMA | variable, as published/received | |
China NMPA | variable, as published/received | |
Canada HC | variable, as published/received | |
Israel MOH | variable, as published/received | |
Italy AIFA | variable, as published/received | |
Japan MHLW | variable, as published/received | |
Mexico COFEPRIS | variable, as published/received | |
Saudi Arabia SFDA | variable, as published/received | |
South Korea MFDS | variable, as published/received | |
Turkey TITCK | variable, as published/received | |
US Filings & Approvals | US FDA | weekly, as published by source |
Product Bioequivalence Recommendations | US FDA | monthly, as published by source |
Content set | Sources | Frequency |
Launched Drug Forms | IQVIA | quarterly, as received |
Launches: Additional Insights | Global Pricing Innovations | monthly |
US Label Information | NIH Dailymed | monthly, as published by source |
Content set | Sources | Frequency |
Constraint Date Forecast | Proprietary algorithm | weekly |
Exclusivities | Regulatory agencies | variable, as published/received |
Content set | Sources | Frequency |
Patent Families | Proprietary | weekly |
Patents | Proprietary | weekly |
Patent Type | Proprietary | weekly |
SPCs | Proprietary | weekly |
Content set | Sources | Frequency |
US Patent Challenges | Proprietary | daily |
Content set | Sources | Frequency |
Deals | Proprietary | weekly |
Content set | Sources | Frequency |
Route of Synthesis | Proprietary | weekly |
Content set | Sources | Frequency |
Manufacturing Capabilities | Company publication | weekly, as published by source |
FDA Inspection date | US FDA | bi-annual, as published by source |
Facility Inspections | Regulatory agencies | variable, as published/received |
Content set | Sources | Frequency |
Corporate Group Type | Proprietary algorithm | weekly |
Corporate API Rating | Proprietary algorithm | weekly |
Associated Subsidiaries | Company publication | weekly, as published by source |
Dose Forms Summary | IQVIA | quarterly, as received |
Financial History and Sales Forecast | Refinitiv | weekly, as published by source |
Content set | Sources | Frequency |
US Market Share | IBM Watson Health | quarterly |
Content set | Sources | Frequency |
LATAM Market Share | Close-Up International | monthly |
Content set | Sources | Frequency |
Global Pricing Trends | Global Pricing Innovations | monthly |
Latest content release notes
Cortellis family
Explore training resources for other Cortellis products.
Sign up for live training or get in touch with our Cortellis training team to request custom training for your organization.